Eyenovia Shares Drop 14% Amid Betaliq Merger Talks
Combining Eyenovia's Optejet dispensing system with Betaliq's EyeSol medication delivery mechanism, the purchase would create ...
Eyenovia Enters into Non-Binding Letter of Intent to Effect Reverse Merger with Betaliq
Combination, if successful, would create a new publicly-listed eye care company combining Betaliq’s EyeSol® water-free drug delivery technology for glaucoma with Eyenovia’s Optejet® device platform ...
Eyenovia enters non-binding LOI to effect reverse merger with Betaliq
Eyenovia (EYEN), has entered into a non-binding letter of intent contemplating a potential reverse merger transaction with Betaliq, a clinical ...
Eyenovia falls on plans to seek reverse merger
Eyenovia (EYEN) stock falls as the company plans a reverse merger with Betaliq, to create an ophthalmology focused drugmaker. Read more here.
Eyenovia Plans All-Stock Reverse Merger With Betaliq
Eyenovia on Thursday said it has signed a non-binding letter of intent to combine with clinical-stage pharmaceutical company Betaliq in an all-stock reverse merger. Eyenovia said Betaliq investors ...
HC Wainwright Reiterates Neutral Rating for Eyenovia (NASDAQ:EYEN)
HC Wainwright restated their neutral rating on shares of Eyenovia (NASDAQ:EYEN – Free Report) in a report published on Friday morning,Benzinga reports. HC Wainwright currently has a $2.00 target price ...
Eyenovia, Inc.: Eyenovia Enters into Non-Binding Letter of Intent to Effect Reverse Merger with Betaliq
Combination, if successful, would create a new publicly-listed eye care company combining Betaliq's EyeSol® water-free drug delivery technology for glaucoma with Eyenovia's Optejet® device platform Th ...
Nasdaq5d
Eyenovia and Betaliq Explore Merger to Form New Ophthalmic Company Combining Innovative Drug Delivery Technologies for Glaucoma Treatment
Eyenovia, Inc. has announced a non-binding letter of intent for a potential reverse merger with Betaliq, Inc., which focuses on glaucoma treatments. If the merger is successful, it would create a ...
The National Law Review5d
Eyenovia Enters into Non-Binding Letter of Intent to Effect Reverse Merger with Betaliq
Combination, if successful, would create a new publicly-listed eye care company combining Betaliq’s EyeSol ® water-free drug delivery technology for glaucoma with Eyenovia’s Optejet ® device ...
manilatimes6d
Eyenovia Enters into Non-Binding Letter of Intent to Effect Reverse Merger with Betaliq
Combination, if successful, would create a new publicly-listed eye care company combining Betaliq's EyeSol ® water-free drug delivery technology for glaucoma with Eyenovia's Optejet ® device platform ...